1. Home
  2. LWAY vs SENS Comparison

LWAY vs SENS Comparison

Compare LWAY & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LWAY

Lifeway Foods Inc.

HOLD

Current Price

$29.39

Market Cap

368.4M

ML Signal

HOLD

Logo Senseonics Holdings Inc.

SENS

Senseonics Holdings Inc.

HOLD

Current Price

$5.72

Market Cap

301.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
LWAY
SENS
Founded
1986
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Industrial Machinery/Components
Sector
Consumer Staples
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
368.4M
301.2M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
LWAY
SENS
Price
$29.39
$5.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$34.50
$18.38
AVG Volume (30 Days)
142.1K
551.8K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
48.33
N/A
EPS
0.30
N/A
Revenue
$103,350,000.00
$16,389,000.00
Revenue This Year
$16.64
$74.15
Revenue Next Year
$17.28
$58.60
P/E Ratio
$101.10
N/A
Revenue Growth
N/A
19.85
52 Week Low
$17.31
$0.41
52 Week High
$34.20
$8.75

Technical Indicators

Market Signals
Indicator
LWAY
SENS
Relative Strength Index (RSI) 69.88 37.97
Support Level $22.03 $5.40
Resistance Level $34.20 $5.94
Average True Range (ATR) 1.35 0.46
MACD 0.66 -0.21
Stochastic Oscillator 75.88 15.22

Price Performance

Historical Comparison
LWAY
SENS

About LWAY Lifeway Foods Inc.

Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.

About SENS Senseonics Holdings Inc.

Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.

Share on Social Networks: